A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

Clinical trial NCT06630559 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06630559
Sponsor: Celltrion
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2025-05-26
Primary completion: 2026-02-18
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.